Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
The Journal of Clinical Investigation|March 1, 1975
Complement fixation by rheumatoid factorK Tanimoto, N R Cooper, J S Johnson, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1988
CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cellsC Mold, G R Nemerow, B M Bradt, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1973
Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantiseraS Ferrone, N R Cooper, M A Pellegrino, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1990
Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesisP Mathias, D C Shreffler, N R Cooper, et al.Community Mental Health Journal|November 5, 2013
Some factors relating to success and failure of male chronic schizophrenics on their first foster home placementS H Simon, W Heggestad, J HopkinsPhysical Review Letters|September 26, 2012
Fractional quantum Hall effect of lattice bosons near commensurate fluxL Hormozi, G Möller, S H SimonThe Journal of Experimental Medicine|October 1, 1976
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathwayN R Cooper, F C Jensen, R M Welsh, et al.Complement and Inflammation|January 1, 1989
Transfected cDNA directs expression of hemolytically active murine C4 in cultured mouse and monkey cellsM A Picchi, B M Bradt, N R Cooper, et al.Neuroscience|December 13, 2000
beta1 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathwayE Bonfoco, W Chen, R Paul, et al.Journal of Virology|March 1, 1990
Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infectionG R Nemerow, J J Mullen, P W Dickson, et al.Pageof 16